As of 2026-03-17, the Relative Valuation of Ocular Therapeutix Inc (OCUL) is (22.11) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.63 USD, the upside of Ocular Therapeutix Inc based on Relative Valuation is -356.2%.
The range of the Relative Valuation is (21.38) - (23.63) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.5x - 19.3x | 18.7x |
| Forward P/E multiples | 15.4x - 19.4x | 17.5x |
| Fair Price | (21.38) - (23.63) | (22.11) |
| Upside | -347.7% - -373.8% | -356.2% |
| Date | P/E |
| 2026-03-12 | -7.26 |
| 2026-03-11 | -7.78 |
| 2026-03-10 | -8.08 |
| 2026-03-09 | -8.14 |
| 2026-03-06 | -8.41 |
| 2026-03-05 | -8.46 |
| 2026-03-04 | -9.04 |
| 2026-03-03 | -8.81 |
| 2026-03-02 | -8.99 |
| 2026-02-27 | -7.32 |
| 2026-02-26 | -7.85 |
| 2026-02-25 | -7.78 |
| 2026-02-24 | -7.33 |
| 2026-02-23 | -6.88 |
| 2026-02-20 | -6.37 |
| 2026-02-19 | -5.75 |
| 2026-02-18 | -5.63 |
| 2026-02-17 | -5.72 |
| 2026-02-13 | -7.27 |
| 2026-02-12 | -7.42 |
| 2026-02-11 | -7.50 |
| 2026-02-10 | -7.39 |
| 2026-02-09 | -7.72 |
| 2026-02-06 | -7.50 |
| 2026-02-05 | -7.29 |
| 2026-02-04 | -7.00 |
| 2026-02-03 | -6.97 |
| 2026-02-02 | -7.49 |
| 2026-01-30 | -7.48 |
| 2026-01-29 | -8.14 |
| 2026-01-28 | -8.41 |
| 2026-01-27 | -8.88 |
| 2026-01-26 | -8.91 |
| 2026-01-23 | -8.41 |
| 2026-01-22 | -9.10 |
| 2026-01-21 | -9.35 |
| 2026-01-20 | -9.37 |
| 2026-01-16 | -9.23 |
| 2026-01-15 | -9.23 |
| 2026-01-14 | -9.06 |
| 2026-01-13 | -8.54 |
| 2026-01-12 | -8.75 |
| 2026-01-09 | -9.22 |
| 2026-01-08 | -9.32 |
| 2026-01-07 | -9.41 |
| 2026-01-06 | -9.21 |
| 2026-01-05 | -9.45 |
| 2026-01-02 | -9.68 |
| 2025-12-31 | -9.94 |
| 2025-12-30 | -9.99 |